Oruka Therapeutics (ORKA) Other Accumulated Expenses (2010 - 2024)
Oruka Therapeutics' quarterly Other Accumulated Expenses came in at $591000.0 in Q2 2024, down 49.53% year-on-year from $1.2 million in Q3 2023, and down 38.95% quarter-over-quarter from $968000.0 in Q1 2024.
Oruka Therapeutics has reported Other Accumulated Expenses for 15 years, with the latest figure at $591000.0 in Q2 2024.
- For the quarter ending Q2 2024, Other Accumulated Expenses fell 49.53% year-over-year to $591000.0; the trailing twelve-month figure through Jun 2024 stood at $591000.0 (down 49.53% YoY), and the FY2023 full-year result was $175000.0, down 72.0% from the prior year.
- Other Accumulated Expenses for Q2 2024 stood at $591000.0, down from $968000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $1.9 million in Q3 2021, with the low at $175000.0 in Q4 2023.
- Average Other Accumulated Expenses over 5 years is $959277.8, with a median of $939500.0 recorded in 2020.
- Year-over-year, Other Accumulated Expenses surged 249.54% in 2021 and sank 72.0% in 2023.
- Tracing ORKA's Other Accumulated Expenses over 5 years: stood at $911000.0 in 2020, then jumped by 59.82% to $1.5 million in 2021, then tumbled by 57.07% to $625000.0 in 2022, then slumped by 72.0% to $175000.0 in 2023, then jumped by 237.71% to $591000.0 in 2024.
- The last three Other Accumulated Expenses figures came in at $591000.0 (Q2 2024), $968000.0 (Q1 2024), and $175000.0 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 591,000.00 |
| Mar 31, 2024 | 968,000.00 |
| Dec 31, 2023 | 175,000.00 |
| Sep 30, 2023 | 582,000.00 |
| Jun 30, 2023 | 1.17 Mn |
| Mar 31, 2023 | 665,000.00 |
| Dec 31, 2022 | 625,000.00 |
| Sep 30, 2022 | 1.01 Mn |
| Jun 30, 2022 | 1.38 Mn |
| Mar 31, 2022 | 1.54 Mn |
| Dec 31, 2021 | 1.46 Mn |
| Sep 30, 2021 | 1.91 Mn |
| Jun 30, 2021 | 1.30 Mn |
| Mar 31, 2021 | 1.05 Mn |
| Dec 31, 2020 | 911,000.00 |
| Sep 30, 2020 | 545,000.00 |
| Jun 30, 2020 | 600,000.00 |
| Mar 31, 2020 | 799,000.00 |
| Dec 31, 2019 | 379,000.00 |
| Sep 30, 2019 | 857,000.00 |
| Jun 30, 2019 | 831,000.00 |
| Mar 31, 2019 | 822,000.00 |
| Dec 31, 2018 | 413,000.00 |
| Sep 30, 2018 | 577,000.00 |
| Jun 30, 2018 | 520,000.00 |
| Mar 31, 2018 | 708,000.00 |
| Dec 31, 2017 | 691,000.00 |
| Sep 30, 2017 | 1.11 Mn |
| Jun 30, 2017 | 1.31 Mn |
| Mar 31, 2017 | 1.30 Mn |
| Dec 31, 2016 | 472,000.00 |
| Sep 30, 2016 | 853,000.00 |
| Jun 30, 2016 | 837,000.00 |
| Mar 31, 2016 | 439,000.00 |
| Dec 31, 2015 | 471,000.00 |
| Sep 30, 2015 | 543,000.00 |
| Jun 30, 2015 | 440,000.00 |
| Mar 31, 2015 | 359,000.00 |
| Dec 31, 2014 | 264,000.00 |
| Sep 30, 2014 | 374,000.00 |
| Jun 30, 2014 | 351,000.00 |
| Mar 31, 2014 | 457,000.00 |
| Dec 31, 2013 | 446,000.00 |
| Sep 30, 2013 | 247,000.00 |
| Jun 30, 2013 | 257,000.00 |
| Mar 31, 2013 | 383,000.00 |
| Dec 31, 2012 | 121,000.00 |
| Sep 30, 2012 | 63,000.00 |
| Jun 30, 2012 | 141,000.00 |
| Mar 31, 2012 | 357,000.00 |
| Dec 31, 2011 | 350,000.00 |
| Sep 30, 2011 | 270,000.00 |
| Jun 30, 2011 | 339,000.00 |
| Dec 31, 2010 | 506,000.00 |